PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Molecular Hepatology10.3350/cmh.2022.00822022283553-564Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipientsKa Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui, Xianhua Mao, Ruiqi R Zhang, Kwok Hung Chan, Ivan FN Hung, Wai Kay Seto, Man-Fung Yuenhttp://e-cmh.org/upload/pdf/cmh-2022-0082.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0082, http://e-cmh.org/upload/pdf/cmh-2022-0082.pdf
Vaccines10.3390/vaccines110304972023113497Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 RecipientsKa Shing Cheung, Lok Ka Lam, Xianhua Mao, Jing Tong Tan, Poh Hwa Ooi, Ruiqi Zhang, Kwok Hung Chan, Ivan F. N. Hung, Wai Kay Seto, Man Fung Yuenhttps://www.mdpi.com/2076-393X/11/3/497/pdf
The Lancet Microbe10.1016/s2666-5247(22)00335-4202343e131Omicron sublineage recombinant XBB evades neutralising antibodies in recipients of BNT162b2 or CoronaVac vaccinesXiaojuan Zhang, Lin-Lei Chen, Jonathan Daniel Ip, Wan-Mui Chan, Ivan Fan-Ngai Hung, Kwok-Yung Yuen, Xin Li, Kelvin Kai-Wang Tohttps://api.elsevier.com/content/article/PII:S2666524722003354?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2666524722003354?httpAccept=text/plain
10.21203/rs.3.rs-2316160/v12022BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses Among Transplant Recipients Who Had Received Two Doses of CoronaVacÇiğdem Erol, Zeynep Ece Kuloğlu, Bircan Kayaaslan, Gülen Esken, Adalet Altınsoy, Tayfun Barlas, Güle Çınar, İmran Hasanoğlu, Ebru Oruç, Said İncir, Alpay Azap, Gülten Korkmaz, Dilara Turan Gökçe, Onur Elvan Kırımker, Ezgi Coşkun Yenigün, Erkan Ölçücüoğlu, Ebru Ayvazoğlu Soy, Süleyman Çetinkünar, Özlem Kurt Azap, Füsun Can, Mehmet Haberalhttps://www.researchsquare.com/article/rs-2316160/v1, https://www.researchsquare.com/article/rs-2316160/v1.html
Journal of Medical Virology10.1002/jmv.2762020229452212-2221An analysis of antibody response following the second dose of CoronaVac and humoral response after booster dose with BNT162b2 or CoronaVac among healthcare workers in TurkeyDerya Çağlayan, Ahmet F. Süner, Neslişah Şiyve, Irmak Güzel, Çağlar Irmak, Elif Işik, Özgür Appak, Muammer Çelik, Gamze Öztürk, Sema Alp Çavuş, Gül Ergör, Arzu Sayiner, Alp Ergör, Yücel Demiral, Bülent Kiliçhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27620, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jmv.27620, https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27620
Transplant International10.3389/ti.2022.10321202235Antibody Response After a Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Liver Transplant RecipientsAkiyoshi Sakai, Tetsuji Morishita, Hidetoshi Matsunamihttps://www.frontierspartnerships.org/articles/10.3389/ti.2022.10321/full
The Lancet10.1016/s0140-6736(21)01594-4202139810297298-299Antibody response after second BNT162b2 dose in allogeneic HSCT recipientsRabah Redjoul, Anne Le Bouter, Florence Beckerich, Slim Fourati, Sébastien Mauryhttps://api.elsevier.com/content/article/PII:S0140673621015944?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0140673621015944?httpAccept=text/plain
Journal of Medical Virology10.1002/jmv.27350202194139-41SARS‐CoV‐2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two‐dose CoronaVac vaccine regimenAli Umit Keskin, Sibel Bolukcu, Pinar Ciragil, Aynur Eren Topkayahttps://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27350, https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jmv.27350, https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27350
Gastroenterology10.1016/s0016-5085(20)34188-320201586S-1408Mo1452 NAFLD PREDICTIVE INDEX: A NOVEL, IMPROVED INDEX TO PREDICT MODERATE TO SEVERE HEPATIC STEATOSIS IN THE U.S. POPULATIONAayush Visaria, Debashis Reja, Suraj Pai, Vinod K. Rustglhttps://api.elsevier.com/content/article/PII:S0016508520341883?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508520341883?httpAccept=text/plain
The Lancet Haematology10.1016/s2352-3026(21)00274-x2021810e681-e683Antibody response after third BNT162b2 dose in recipients of allogeneic HSCTRabah Redjoul, Anne Le Bouter, Vincent Parinet, Slim Fourati, Sébastien Mauryhttps://api.elsevier.com/content/article/PII:S235230262100274X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S235230262100274X?httpAccept=text/plain